Germany
Japan
United Kingdom
China
Rabbit monoclonal anti-TXND5 antibody for SISCAPA, clone OTIR4D8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Products
Rabbit monoclonal anti-NNMT antibody for SISCAPA, clone OTIR1F6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-PDIA3 antibody for SISCAPA, clone OTIR5G4
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-P5CR1 antibody for SISCAPA, clone OTIR1E8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CADH6 antibody for SISCAPA, clone OTIR5A6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CHK1 antibody for SISCAPA, clone OTIR3G7
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-ERK3 antibody for SISCAPA, clone OTIR5F3
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-FOXO1 antibody for SISCAPA, clone OTIR3H6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-LGR5 mouse mAb, clone OTI2A2, DyLight 550 conjugated
| Reactivities | Human, Mouse |
| Conjugation | DyLight 550 |
ZCCHC24 mouse monoclonal antibody, clone OTI2E1 (formerly 2E1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3C2-4
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3G11-14
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5F4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5G12-21
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6F5-23
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6H8-22
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8E8-2
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8F6-6
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 524.00
In Stock
Anti-LGR5 mouse mAb, clone OTI2A2, HRP conjugated
| Reactivities | Human, Mouse |
| Conjugation | HRP |
Mouse Monoclonal anti-CACNA1C Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 379.00
In Stock
USD 440.00
2 Weeks
Mouse Monoclonal anti-CACNA1D Antibody
| Applications | IF |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 379.00
In Stock
Mouse Monoclonal anti-Syk Antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Mouse Monoclonal alpha Tubulin Antibody (DM1A) - Microtubule Marker
| Applications | IHC, WB |
| Reactivities | Bovine, Chicken, Guinea Pig, Human, Mouse, Porcine, Rat, Xenopus |
| Conjugation | Unconjugated |
Active filters
Reactivities
- Mouse
Clonalities
- Monoclonal
Filter by
Target Symbol
- VSNL1 (270)
- ALK (268)
- MAP2K1 (213)
- ERBB2 (198)
- NME1 (167)
- ABCB1 (160)
- JUN (155)
- ERCC1 (151)
- MAP2K3 (150)
- GLI1 (148)
- GADD45G (130)
- CTNNB1 (127)
- OTC (125)
- VIM (115)
- EGFR (112)
- PIK3C2A (110)
- PCNA (108)
- NUMB (106)
- TOP2A (96)
- LGALS3 (95)
- MAPK13 (95)
- UBE2E3 (95)
- L1CAM (91)
- SENP2 (90)
- APP (87)
- PNMT (85)
- F13A1 (84)
- NKX2-1 (84)
- TYMS (83)
- MIEN1 (80)
- BRAF (79)
- MLH1 (79)
- PDCD1 (76)
- ALDH1L1 (74)
- LGR5 (74)
- PARVA (70)
- SPG7 (70)
- UBA52 (70)
- AKT1 (68)
- BCL2 (68)
- AFAP1 (65)
- BCL10 (65)
- CNOT4 (65)
- GFAP (65)
- LTA4H (65)
- PTPRE (65)
- NCAM1 (64)
- CBX8 (63)
- LOX (63)
- PIK3AP1 (63)
- SNAI2 (63)
- STAT5A (63)
- SQSTM1 (62)
- STAT4 (61)
- ABAT (60)
- EFNA2 (60)
- LPL (60)
- MIOX (60)
- PIK3CG (60)
- PSMC3 (60)
- RNF144B (60)
- ZFP36 (60)
- BTK (59)
- FSHB (59)
- LDLRAP1 (59)
- MAPK1 (59)
- MEF2C (59)
- SMS (59)
- TLE1 (59)
- PCDH7 (58)
- PRKCE (58)
- MTOR (57)
- VBP1 (57)
- BBOX1 (56)
- ERG (56)
- ACAT2 (55)
- ARHGAP25 (55)
- CCM2 (55)
- CRYAB (55)
- DPP9 (55)
- KRAS (55)
- MAPK7 (55)
- MOB3B (55)
- NAB1 (55)
- NPR3 (55)
- NRBF2 (55)
- SOCS3 (55)
- SYP (55)
- TTLL12 (55)
- ZNF365 (55)
- FGFR2 (54)
- KCNAB1 (54)
- MSI1 (54)
- CDK2 (53)
- DPP3 (53)
- MCM2 (53)
- PSMD2 (53)
- RRM1 (53)
- TNNT2 (53)
- NEUROG1 (51)
Applications
Antibody Hosts
Isotypes
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (34)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- Phospho-specific (10)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- Modification (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (22717)
- Transcription Factors (7316)
- Transmembrane (4322)
- Protein Kinase (3539)
- ES Cell Differentiation/IPS (2819)
- Protease (1683)
- Stem cell - Pluripotency (1678)
- Secreted Protein (1590)
- Adult stem cells (706)
- Nuclear Hormone Receptor (654)
- Phosphatase (521)
- Embryonic stem cells (470)
- Cancer stem cells (437)
- Stem cell relevant signaling - DSL/Notch pathway (321)
- Stem cell relevant signaling - JAK/STAT signaling pathway (312)
- Ion Channels: Other (205)
- Induced pluripotent stem cells (187)
- GPCR (175)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (146)
- P450 (84)
- Stem cell relevant signaling - Wnt Signaling pathway (54)
- Ion Channels: Potassium (50)
- Ion Channels: Cys-loop Receptors (28)
- Ion Channels: Transient receptor potential (10)
- Ion Channels: Calcium (3)
- Ion Channels: Glutamate Receptors (2)
- Ion Channels: Sodium (2)
- Ion Channels: Cyclic nucleotide gated (1)
Pathways
- Metabolic pathways (4110)
- Pathways in cancer (3332)
- MAPK signaling pathway (2504)
- Focal adhesion (2078)
- Prostate cancer (1793)
- Colorectal cancer (1686)
- ErbB signaling pathway (1643)
- Neurotrophin signaling pathway (1578)
- Endometrial cancer (1380)
- Regulation of actin cytoskeleton (1345)
- Insulin signaling pathway (1333)
- Pancreatic cancer (1331)
- T cell receptor signaling pathway (1317)
- Progesterone-mediated oocyte maturation (1283)
- Non-small cell lung cancer (1264)
- B cell receptor signaling pathway (1262)
- Toll-like receptor signaling pathway (1244)
- GnRH signaling pathway (1218)
- Melanoma (1188)
- Glioma (1172)
- Fc epsilon RI signaling pathway (1168)
- Renal cell carcinoma (1155)
- Acute myeloid leukemia (1094)
- Chronic myeloid leukemia (1092)
- Bladder cancer (1029)
- Chemokine signaling pathway (961)
- VEGF signaling pathway (949)
- Cell cycle (928)
- Purine metabolism (886)
- Endocytosis (883)
- Wnt signaling pathway (871)
- Gap junction (860)
- Adherens junction (812)
- Fc gamma R-mediated phagocytosis (787)
- Natural killer cell mediated cytotoxicity (780)
- Leukocyte transendothelial migration (759)
- Small cell lung cancer (719)
- Oocyte meiosis (715)
- Epithelial cell signaling in Helicobacter pylori infection (698)
- Thyroid cancer (687)
- Pyrimidine metabolism (661)
- Melanogenesis (660)
- Alzheimer's disease (658)
- mTOR signaling pathway (656)
- Ubiquitin mediated proteolysis (652)
- Calcium signaling pathway (643)
- Long-term potentiation (635)
- Axon guidance (622)
- Apoptosis (603)
- Jak-STAT signaling pathway (602)
- Long-term depression (589)
- Tight junction (586)
- Type II diabetes mellitus (577)
- Amyotrophic lateral sclerosis (ALS) (560)
- Vascular smooth muscle contraction (525)
- Nucleotide excision repair (513)
- Glycolysis / Gluconeogenesis (508)
- Arginine and proline metabolism (485)
- Basal cell carcinoma (481)
- Dorso-ventral axis formation (481)
- Adipocytokine signaling pathway (477)
- Huntington's disease (463)
- Hedgehog signaling pathway (455)
- p53 signaling pathway (446)
- Prion diseases (431)
- Cytokine-cytokine receptor interaction (430)
- Pathogenic Escherichia coli infection (422)
- Cell adhesion molecules (CAMs) (404)
- TGF-beta signaling pathway (400)
- Proteasome (396)
- Parkinson's disease (377)
- RNA degradation (361)
- Valine (349)
- NOD-like receptor signaling pathway (345)
- Phosphatidylinositol signaling system (342)
- leucine and isoleucine degradation (338)
- Inositol phosphate metabolism (335)
- Spliceosome (326)
- Mismatch repair (311)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (295)
- Oxidative phosphorylation (295)
- DNA replication (293)
- Alanine (292)
- aspartate and glutamate metabolism (292)
- Hypertrophic cardiomyopathy (HCM) (291)
- Notch signaling pathway (284)
- Pyruvate metabolism (273)
- Dilated cardiomyopathy (267)
- Base excision repair (262)
- One carbon pool by folate (260)
- Tyrosine metabolism (257)
- Fatty acid metabolism (250)
- Lysine degradation (245)
- Butanoate metabolism (244)
- RIG-I-like receptor signaling pathway (243)
- Propanoate metabolism (233)
- ABC transporters (231)
- Glycine (214)
- serine and threonine metabolism (214)
- Glutathione metabolism (210)
- Neuroactive ligand-receptor interaction (209)
- Antigen processing and presentation (202)
- Maturity onset diabetes of the young (197)
- Primary immunodeficiency (191)
- PPAR signaling pathway (186)
- Arachidonic acid metabolism (185)
- Vibrio cholerae infection (182)
- Histidine metabolism (175)
- Tryptophan metabolism (170)
- beta-Alanine metabolism (169)
- Cardiac muscle contraction (167)
- SNARE interactions in vesicular transport (156)
- Citrate cycle (TCA cycle) (154)
- Cysteine and methionine metabolism (143)
- Amino sugar and nucleotide sugar metabolism (141)
- Pentose phosphate pathway (137)
- Porphyrin and chlorophyll metabolism (135)
- Glycerolipid metabolism (133)
- Starch and sucrose metabolism (133)
- Circadian rhythm - mammal (131)
- Complement and coagulation cascades (127)
- Drug metabolism - cytochrome P450 (125)
- Terpenoid backbone biosynthesis (123)
- Drug metabolism - other enzymes (120)
- Viral myocarditis (120)
- Ribosome (119)
- Fructose and mannose metabolism (114)
- Lysosome (111)
- Methane metabolism (111)
- Fatty acid elongation in mitochondria (108)
- RNA polymerase (103)
- Metabolism of xenobiotics by cytochrome P450 (96)
- Regulation of autophagy (95)
- Retinol metabolism (94)
- Glyoxylate and dicarboxylate metabolism (88)
- Hematopoietic cell lineage (85)
- Selenoamino acid metabolism (84)
- Renin-angiotensin system (83)
- Ascorbate and aldarate metabolism (81)
- Nicotinate and nicotinamide metabolism (81)
- ECM-receptor interaction (80)
- N-Glycan biosynthesis (80)
- Galactose metabolism (78)
- Systemic lupus erythematosus (75)
- Cytosolic DNA-sensing pathway (74)
- Nitrogen metabolism (72)
- Synthesis and degradation of ketone bodies (70)
- Type I diabetes mellitus (69)
- Basal transcription factors (67)
- Folate biosynthesis (61)
- Olfactory transduction (61)
- Glycerophospholipid metabolism (56)
- Phenylalanine metabolism (56)
- Androgen and estrogen metabolism (54)
- Sulfur metabolism (50)
- Homologous recombination (49)
- Ether lipid metabolism (45)
- Pantothenate and CoA biosynthesis (40)
- Other glycan degradation (38)
- Sphingolipid metabolism (38)
- Caffeine metabolism (36)
- Aminoacyl-tRNA biosynthesis (35)
- Primary bile acid biosynthesis (35)
- Cyanoamino acid metabolism (30)
- Thiamine metabolism (30)
- Vitamin B6 metabolism (30)
- Riboflavin metabolism (29)
- Keratan sulfate biosynthesis (25)
- Fatty acid biosynthesis (22)
- Non-homologous end-joining (22)
- Glycosphingolipid biosynthesis - lacto and neolacto series (21)
- Limonene and pinene degradation (21)
- Glycosaminoglycan degradation (20)
- Taste transduction (20)
- Autoimmune thyroid disease (17)
- Allograft rejection (16)
- Graft-versus-host disease (16)
- leucine and isoleucine biosynthesis (16)
- D-Glutamine and D-glutamate metabolism (15)
- Taurine and hypotaurine metabolism (15)
- Biosynthesis of unsaturated fatty acids (11)
- Linoleic acid metabolism (11)
- Phenylalanine (11)
- tyrosine and tryptophan biosynthesis (11)
- O-Glycan biosynthesis (10)
- Protein export (10)
- Steroid biosynthesis (10)
- alpha-Linolenic acid metabolism (10)
- Pentose and glucuronate interconversions (7)
- Glycosphingolipid biosynthesis - ganglio series (5)
- Ubiquinone and other terpenoid-quinone biosynthesis (5)